Loading…

Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations

Botulinum neurotoxins (BoNTs) are important therapeutic agents. The in vivo median lethal dose (LD50) assay has been commonly used to measure the potency of BoNT commercial preparations. As an alternative, we developed cell-based assays for abobotulinumtoxinA in both powder (Dysport®, Azzalure®) and...

Full description

Saved in:
Bibliographic Details
Published in:Toxins 2023-04, Vol.15 (5), p.314
Main Authors: Fonfria, Elena, Marks, Elizabeth, Foulkes, Lisa-Marie, Schofield, Rebecca, Higazi, Daniel, Coward, Sam, Kippen, Alistair
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c462t-8d62074fa5d377a024539fa1b189ee5dbbbf9f8ad9617524b2b71ef561cc34f33
cites cdi_FETCH-LOGICAL-c462t-8d62074fa5d377a024539fa1b189ee5dbbbf9f8ad9617524b2b71ef561cc34f33
container_end_page
container_issue 5
container_start_page 314
container_title Toxins
container_volume 15
creator Fonfria, Elena
Marks, Elizabeth
Foulkes, Lisa-Marie
Schofield, Rebecca
Higazi, Daniel
Coward, Sam
Kippen, Alistair
description Botulinum neurotoxins (BoNTs) are important therapeutic agents. The in vivo median lethal dose (LD50) assay has been commonly used to measure the potency of BoNT commercial preparations. As an alternative, we developed cell-based assays for abobotulinumtoxinA in both powder (Dysport®, Azzalure®) and liquid (Alluzience®) formulations using the in vitro BoCell® system. The assays demonstrated linearity over 50–130% of the expected relative potency, with a correlation coefficient of 0.98. Mean recoveries of 90–108% of the stated potency were observed over this range. The coefficients of variation for powder and liquid formulations, respectively, were 3.6% and 4.0% for repeatability and 8.3% and 5.0% for intermediate precision. A statistically powered comparability assessment of the BoCell® and LD50 assays was performed. Equivalence was demonstrated between the assays for the liquid formulation at release and end of shelf life using a paired equivalence test with predefined equivalence margins. For the powder formulation, the assays were also shown to be equivalent for release samples and when determining loss of potency following thermal degradation. The BoCell® assay was approved for establishing the potency of abobotulinumtoxinA for both powder and liquid formulations in Europe and for the powder formulation only in the USA.
doi_str_mv 10.3390/toxins15050314
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_3ffd446e80d14f4daed9b07ee3ec6b6d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_3ffd446e80d14f4daed9b07ee3ec6b6d</doaj_id><sourcerecordid>2820024104</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-8d62074fa5d377a024539fa1b189ee5dbbbf9f8ad9617524b2b71ef561cc34f33</originalsourceid><addsrcrecordid>eNpdkstuUzEQho8QiFalW9aW2LBJ8e3cVihNKVRKRYVgbfkybhydY6e2T0tehafFSQoieOPL_Ppm5vdU1VuCLxjr8YccfjqfSI1rzAh_UZ1S3NJZ09Tk5T_nk-o8pTUuizHSk_Z1dcJaymrG-9Pq1zfYDFLDCD6jYFFeAboNUwK0vKoxmqckt8iGiK4gQxydl9kF_0d5FzJ4vd1d5yqokKfB-Wnc1zVHTy6vkEQLGIbZpUxg0C3kVTDIeXQZSuwuPBmISHqDlu5hcgZdhzhOwz5HelO9snJIcP68n1U_rj99X3yZLb9-vlnMlzPNG5pnnWlKq9zK2rC2lZjymvVWEkW6HqA2Sinb206aviFtTbmiqiVg64Zozbhl7Ky6OXBNkGuxiW6UcSuCdGL_EOK9kDE7PYBg1hrOG-iwIdxyI8H0CrcADHSjGlNYHw-szaRGMLq4GuVwBD2OeLcS9-FREEwp7igvhPfPhBgeJkhZjC7pYqH0UP5F0I7i0iPBO-m7_6TrMEVfvCoq0vOOF2hRXRxUOoaUIti_1RAsdmMkjseI_QaVkLyD</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2819484022</pqid></control><display><type>article</type><title>Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations</title><source>ProQuest - Publicly Available Content Database</source><source>PubMed Central</source><creator>Fonfria, Elena ; Marks, Elizabeth ; Foulkes, Lisa-Marie ; Schofield, Rebecca ; Higazi, Daniel ; Coward, Sam ; Kippen, Alistair</creator><creatorcontrib>Fonfria, Elena ; Marks, Elizabeth ; Foulkes, Lisa-Marie ; Schofield, Rebecca ; Higazi, Daniel ; Coward, Sam ; Kippen, Alistair</creatorcontrib><description>Botulinum neurotoxins (BoNTs) are important therapeutic agents. The in vivo median lethal dose (LD50) assay has been commonly used to measure the potency of BoNT commercial preparations. As an alternative, we developed cell-based assays for abobotulinumtoxinA in both powder (Dysport®, Azzalure®) and liquid (Alluzience®) formulations using the in vitro BoCell® system. The assays demonstrated linearity over 50–130% of the expected relative potency, with a correlation coefficient of 0.98. Mean recoveries of 90–108% of the stated potency were observed over this range. The coefficients of variation for powder and liquid formulations, respectively, were 3.6% and 4.0% for repeatability and 8.3% and 5.0% for intermediate precision. A statistically powered comparability assessment of the BoCell® and LD50 assays was performed. Equivalence was demonstrated between the assays for the liquid formulation at release and end of shelf life using a paired equivalence test with predefined equivalence margins. For the powder formulation, the assays were also shown to be equivalent for release samples and when determining loss of potency following thermal degradation. The BoCell® assay was approved for establishing the potency of abobotulinumtoxinA for both powder and liquid formulations in Europe and for the powder formulation only in the USA.</description><identifier>ISSN: 2072-6651</identifier><identifier>EISSN: 2072-6651</identifier><identifier>DOI: 10.3390/toxins15050314</identifier><identifier>PMID: 37235349</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Accuracy ; Assaying ; botulinum ; CBA ; Coefficient of variation ; Correlation coefficient ; Correlation coefficients ; Equivalence ; In vivo methods and tests ; LD50 ; Lethal dose ; Light ; Neurotoxins ; Pharmacology ; potency ; Powder ; Proteins ; replacement ; Shelf life ; Thermal degradation ; toxin ; Toxins</subject><ispartof>Toxins, 2023-04, Vol.15 (5), p.314</ispartof><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-8d62074fa5d377a024539fa1b189ee5dbbbf9f8ad9617524b2b71ef561cc34f33</citedby><cites>FETCH-LOGICAL-c462t-8d62074fa5d377a024539fa1b189ee5dbbbf9f8ad9617524b2b71ef561cc34f33</cites><orcidid>0000-0001-8816-519X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2819484022/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2819484022?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids></links><search><creatorcontrib>Fonfria, Elena</creatorcontrib><creatorcontrib>Marks, Elizabeth</creatorcontrib><creatorcontrib>Foulkes, Lisa-Marie</creatorcontrib><creatorcontrib>Schofield, Rebecca</creatorcontrib><creatorcontrib>Higazi, Daniel</creatorcontrib><creatorcontrib>Coward, Sam</creatorcontrib><creatorcontrib>Kippen, Alistair</creatorcontrib><title>Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations</title><title>Toxins</title><description>Botulinum neurotoxins (BoNTs) are important therapeutic agents. The in vivo median lethal dose (LD50) assay has been commonly used to measure the potency of BoNT commercial preparations. As an alternative, we developed cell-based assays for abobotulinumtoxinA in both powder (Dysport®, Azzalure®) and liquid (Alluzience®) formulations using the in vitro BoCell® system. The assays demonstrated linearity over 50–130% of the expected relative potency, with a correlation coefficient of 0.98. Mean recoveries of 90–108% of the stated potency were observed over this range. The coefficients of variation for powder and liquid formulations, respectively, were 3.6% and 4.0% for repeatability and 8.3% and 5.0% for intermediate precision. A statistically powered comparability assessment of the BoCell® and LD50 assays was performed. Equivalence was demonstrated between the assays for the liquid formulation at release and end of shelf life using a paired equivalence test with predefined equivalence margins. For the powder formulation, the assays were also shown to be equivalent for release samples and when determining loss of potency following thermal degradation. The BoCell® assay was approved for establishing the potency of abobotulinumtoxinA for both powder and liquid formulations in Europe and for the powder formulation only in the USA.</description><subject>Accuracy</subject><subject>Assaying</subject><subject>botulinum</subject><subject>CBA</subject><subject>Coefficient of variation</subject><subject>Correlation coefficient</subject><subject>Correlation coefficients</subject><subject>Equivalence</subject><subject>In vivo methods and tests</subject><subject>LD50</subject><subject>Lethal dose</subject><subject>Light</subject><subject>Neurotoxins</subject><subject>Pharmacology</subject><subject>potency</subject><subject>Powder</subject><subject>Proteins</subject><subject>replacement</subject><subject>Shelf life</subject><subject>Thermal degradation</subject><subject>toxin</subject><subject>Toxins</subject><issn>2072-6651</issn><issn>2072-6651</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkstuUzEQho8QiFalW9aW2LBJ8e3cVihNKVRKRYVgbfkybhydY6e2T0tehafFSQoieOPL_Ppm5vdU1VuCLxjr8YccfjqfSI1rzAh_UZ1S3NJZ09Tk5T_nk-o8pTUuizHSk_Z1dcJaymrG-9Pq1zfYDFLDCD6jYFFeAboNUwK0vKoxmqckt8iGiK4gQxydl9kF_0d5FzJ4vd1d5yqokKfB-Wnc1zVHTy6vkEQLGIbZpUxg0C3kVTDIeXQZSuwuPBmISHqDlu5hcgZdhzhOwz5HelO9snJIcP68n1U_rj99X3yZLb9-vlnMlzPNG5pnnWlKq9zK2rC2lZjymvVWEkW6HqA2Sinb206aviFtTbmiqiVg64Zozbhl7Ky6OXBNkGuxiW6UcSuCdGL_EOK9kDE7PYBg1hrOG-iwIdxyI8H0CrcADHSjGlNYHw-szaRGMLq4GuVwBD2OeLcS9-FREEwp7igvhPfPhBgeJkhZjC7pYqH0UP5F0I7i0iPBO-m7_6TrMEVfvCoq0vOOF2hRXRxUOoaUIti_1RAsdmMkjseI_QaVkLyD</recordid><startdate>20230429</startdate><enddate>20230429</enddate><creator>Fonfria, Elena</creator><creator>Marks, Elizabeth</creator><creator>Foulkes, Lisa-Marie</creator><creator>Schofield, Rebecca</creator><creator>Higazi, Daniel</creator><creator>Coward, Sam</creator><creator>Kippen, Alistair</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T7</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PATMY</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PYCSY</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8816-519X</orcidid></search><sort><creationdate>20230429</creationdate><title>Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations</title><author>Fonfria, Elena ; Marks, Elizabeth ; Foulkes, Lisa-Marie ; Schofield, Rebecca ; Higazi, Daniel ; Coward, Sam ; Kippen, Alistair</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-8d62074fa5d377a024539fa1b189ee5dbbbf9f8ad9617524b2b71ef561cc34f33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Accuracy</topic><topic>Assaying</topic><topic>botulinum</topic><topic>CBA</topic><topic>Coefficient of variation</topic><topic>Correlation coefficient</topic><topic>Correlation coefficients</topic><topic>Equivalence</topic><topic>In vivo methods and tests</topic><topic>LD50</topic><topic>Lethal dose</topic><topic>Light</topic><topic>Neurotoxins</topic><topic>Pharmacology</topic><topic>potency</topic><topic>Powder</topic><topic>Proteins</topic><topic>replacement</topic><topic>Shelf life</topic><topic>Thermal degradation</topic><topic>toxin</topic><topic>Toxins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fonfria, Elena</creatorcontrib><creatorcontrib>Marks, Elizabeth</creatorcontrib><creatorcontrib>Foulkes, Lisa-Marie</creatorcontrib><creatorcontrib>Schofield, Rebecca</creatorcontrib><creatorcontrib>Higazi, Daniel</creatorcontrib><creatorcontrib>Coward, Sam</creatorcontrib><creatorcontrib>Kippen, Alistair</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Environmental Science Collection</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Toxins</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fonfria, Elena</au><au>Marks, Elizabeth</au><au>Foulkes, Lisa-Marie</au><au>Schofield, Rebecca</au><au>Higazi, Daniel</au><au>Coward, Sam</au><au>Kippen, Alistair</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations</atitle><jtitle>Toxins</jtitle><date>2023-04-29</date><risdate>2023</risdate><volume>15</volume><issue>5</issue><spage>314</spage><pages>314-</pages><issn>2072-6651</issn><eissn>2072-6651</eissn><abstract>Botulinum neurotoxins (BoNTs) are important therapeutic agents. The in vivo median lethal dose (LD50) assay has been commonly used to measure the potency of BoNT commercial preparations. As an alternative, we developed cell-based assays for abobotulinumtoxinA in both powder (Dysport®, Azzalure®) and liquid (Alluzience®) formulations using the in vitro BoCell® system. The assays demonstrated linearity over 50–130% of the expected relative potency, with a correlation coefficient of 0.98. Mean recoveries of 90–108% of the stated potency were observed over this range. The coefficients of variation for powder and liquid formulations, respectively, were 3.6% and 4.0% for repeatability and 8.3% and 5.0% for intermediate precision. A statistically powered comparability assessment of the BoCell® and LD50 assays was performed. Equivalence was demonstrated between the assays for the liquid formulation at release and end of shelf life using a paired equivalence test with predefined equivalence margins. For the powder formulation, the assays were also shown to be equivalent for release samples and when determining loss of potency following thermal degradation. The BoCell® assay was approved for establishing the potency of abobotulinumtoxinA for both powder and liquid formulations in Europe and for the powder formulation only in the USA.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>37235349</pmid><doi>10.3390/toxins15050314</doi><orcidid>https://orcid.org/0000-0001-8816-519X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6651
ispartof Toxins, 2023-04, Vol.15 (5), p.314
issn 2072-6651
2072-6651
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_3ffd446e80d14f4daed9b07ee3ec6b6d
source ProQuest - Publicly Available Content Database; PubMed Central
subjects Accuracy
Assaying
botulinum
CBA
Coefficient of variation
Correlation coefficient
Correlation coefficients
Equivalence
In vivo methods and tests
LD50
Lethal dose
Light
Neurotoxins
Pharmacology
potency
Powder
Proteins
replacement
Shelf life
Thermal degradation
toxin
Toxins
title Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A49%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Replacement%20of%20the%20Mouse%20LD50%20Assay%20for%20Determination%20of%20the%20Potency%20of%20AbobotulinumtoxinA%20with%20a%20Cell-Based%20Method%20in%20Both%20Powder%20and%20Liquid%20Formulations&rft.jtitle=Toxins&rft.au=Fonfria,%20Elena&rft.date=2023-04-29&rft.volume=15&rft.issue=5&rft.spage=314&rft.pages=314-&rft.issn=2072-6651&rft.eissn=2072-6651&rft_id=info:doi/10.3390/toxins15050314&rft_dat=%3Cproquest_doaj_%3E2820024104%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c462t-8d62074fa5d377a024539fa1b189ee5dbbbf9f8ad9617524b2b71ef561cc34f33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2819484022&rft_id=info:pmid/37235349&rfr_iscdi=true